Valeris Appoints Jeff Crowther as Chief Revenue Officer to Elevate Strategy

Valeris Welcomes Jeff Crowther as Chief Revenue Officer

Valeris, a leading partner in life sciences commercialization, recently announced an important addition to its executive team. Jeff Crowther has been appointed as Chief Revenue Officer, a role that positions him at the forefront of the company's ambitious growth and innovation strategy. Reporting directly to Chief Commercial Officer Scott Filosi, Crowther's extensive experience is expected to strengthen Valeris’ commercial operations while keeping the patient as the focal point of its strategies.

With a robust career spanning over three decades, Crowther brings a wealth of knowledge to Valeris. His previous roles have seen him excel in various facets of commercial leadership—including marketing, sales, business development, and operations. His therapeutic expertise is notably diverse, encompassing areas such as oncology, hematology, central nervous system disorders, gastroenterology, and infectious diseases. Before joining Valeris, he served as Senior Vice President of Commercial Operations at Syndax Pharmaceuticals, where he was instrumental in establishing the company's initial sales and marketing frameworks ahead of vital new product launches.

Crowther’s career boasts several significant achievements, including his impactful tenure at SK Life Science, where he played a crucial role in the commercial launch of XCOPRI, recognized as the most successful adult partial-onset seizure product launch in the United States for a decade—despite the challenges presented by the COVID-19 pandemic. His journey in the pharmaceutical industry commenced at Johnson & Johnson, where he laid the groundwork for a successful career in drug commercialization.

By joining Valeris, Crowther acknowledges the company's unique value proposition, noting that he has witnessed its positive impact on patient care first-hand during his previous professional interactions. He is excited to be part of a leadership team committed to enhancing the patient experience, stating, "I am thrilled to be a member of a leadership team committed to transforming the patient experience and I'm confident that we'll do so, ultimately becoming an indispensable business partner to the organizations we support."

Scott Filosi, Chief Commercial Officer at Valeris, highlighted Crowther's ability to build and enhance commercial organizations effectively, noting, "Jeff brings a proven record of building commercial organizations from the ground up and delivering results under real market pressure. His experience will strengthen our team both strategically and from an execution standpoint."

Valeris operates as a fully integrated commercialization partner catering primarily to life sciences companies, providing a comprehensive array of solutions throughout the healthcare value chain. With a focus on improving patient access to essential medications, Valeris leverages an expert team, cutting-edge technology, and insightful data to support its clients. The company's commitment to patient care has already positively influenced millions of patients and facilitated successful product launches for over 500 life sciences customers.

The recruitment of Jeff Crowther is a defining moment for Valeris as the company continues to invest in innovation and growth strategies that place patient needs at the core of its operations. His leadership is poised to foster further advancements in how life sciences companies connect with patients and streamline access to crucial treatments while navigating a rapidly evolving healthcare landscape.

In conclusion, with the addition of Jeff Crowther, Valeris is making strides to enhance its revenue strategies while maintaining a consistent focus on patient-centered care. As the life sciences industry continues to evolve, the leadership team at Valeris is prepared to meet the challenges ahead through strategic growth and innovation.